1994
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson K. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal Of Public Health 1994, 84: 382-7. PMID: 8129052, PMCID: PMC1614821, DOI: 10.2105/ajph.84.3.382.Peer-Reviewed Original ResearchConceptsFemale intravenous drug usersIntravenous drug usersHIV seropositivityHIV infectionDrug usersHuman immunodeficiency virus (HIV) seroprevalenceIntravenous drug useDrug-using womenTrading of sexCohort studyVirus seroprevalenceDrug useCocaine useIntensive interventionLogistic regressionSeropositivityNumber of partnersMultivariate modelDrugsWomenSexInfectionGroupHigh levelsSeroprevalence
1993
Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users
Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson K. Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users. American Journal Of Epidemiology 1993, 137: 892-898. PMID: 8484380, DOI: 10.1093/oxfordjournals.aje.a116750.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionDrug usersSeronegative controlsRisk factorsFemale intravenous drug usersMale intravenous drug usersSex-specific risk factorsCurrent intravenous drug useHIV-seronegative controlsIntravenous drug useRisk of seroconversionRisk factor dataCase-control studyAge 18 yearsConditional logistic regression techniquesTime of interviewMore sex partnersSeroconversion statusSeroconversion visitHIV seroconversionHIV infectionStudy entrySexual transmissionSeroconversion
1989
Prospective Study of Human Immunodeficiency Virus Infection and Pregnancy Outcomes in Intravenous Drug Users
Selwyn P, Schoenbaum E, Davenny K, Robertson V, Feingold A, Shulman J, Mayers M, Klein R, Friedland G, Rogers M. Prospective Study of Human Immunodeficiency Virus Infection and Pregnancy Outcomes in Intravenous Drug Users. JAMA 1989, 261: 1289-1294. PMID: 2915455, DOI: 10.1001/jama.1989.03420090053030.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPregnancy outcomesDrug usersVirus infectionFemale intravenous drug usersHIV disease statusSeropositive pregnant womenAdverse pregnancy outcomesAsymptomatic HIV infectionNeonatal complicationsEctopic pregnancyPreterm deliveryHIV antibodiesBreech presentationHIV infectionSymptomatic diseaseBacterial pneumoniaHIV statusPregnant womenProspective studyWeight birthsAdditional womenMethadone programs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply